C-reactive protein-to-albumin ratio in peripheral artery disease
Open Access
- 1 January 2025
- journal article
- review article
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 20 (1) , 20251280
Abstract
Aim: The aim of this study was to assess the prognostic performance of the C-reactive protein-to-albumin ratio (CAR) in predicting mortality and amputation of peripheral artery disease (PAD) patients undergoing endovascular therapy (EVT). Methods: We conducted a systematic search from the inception date to June 12, 2025, in eight databases and a manual search to cover gray literature. High and low CAR were defined according to the optimal cut-off from each study. Meta-analysis was performed to pool prognostic performance. Result: A total of 1,451 subjects from five observational studies were included. The prevalence of mortality and amputation was 4.7 and 21.4%, respectively. Pre-procedural high CAR was associated with a higher risk of mortality (risk ratio [RR] 3.11; 95% confidence interval [CI] 1.22–8.18; I 2 = 40%) and amputation (RR 3.62; 95% CI 1.98–6.63; I 2 = 10%). The area under the receiver operating characteristic (ROC) curve of the summary ROC curve of high CAR was 0.75 (sensitivity 77% and specificity 56%) for mortality and 0.85 (sensitivity 85% and specificity 52%) for amputation. The positive predictive value of CAR to predict mortality and amputation was 29.9 and 10.5%, respectively, while the negative predictive value was 90.5 and 97.8%, respectively. Conclusion: CAR was a potential prognostic biomarker to predict mortality and amputation in PAD patients undergoing EVT.Keywords
This publication has 35 references indexed in Scilit:
- The roles of C-reactive protein-albumin ratio as a novel prognostic biomarker in heart failure patients: A systematic reviewCurrent Problems in Cardiology, 2024
- Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent ClaudicationEuropean Journal of Vascular and Endovascular Surgery, 2023
- Vascular Surgery in Low-Income and Middle-Income Countries: A State-of-the-Art ReviewAnnals of Vascular Surgery, 2023
- A Novel Marker Indicating Restenosis in Superficial Femoral Artery: C Reactive Protein to Albumin RatioAnnals of Vascular Surgery, 2022
- Association Between CRP/Albumin Ratio and Long-Term Mortality in Patients With cHronIc Limb-Threatening Ischemia Undergoing EndovaScular Therapy Below The Knee: The ACHILES-BTK RegistryAnnals of Vascular Surgery, 2022
- Inflammation as a Mechanism and Therapeutic Target in Peripheral Artery DiseaseCanadian Journal of Cardiology, 2022
- Serum albumin levels and inflammationInternational Journal of Biological Macromolecules, 2021
- Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery DiseaseEuropean Journal of Vascular and Endovascular Surgery, 2017
- Inflammatory Burden Predicts Long-Term Outcomes in Endovascular Therapy in Peripheral Arterial DiseaseAnnals of Vascular Surgery, 2013
- Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertensionAmerican Heart Journal, 2007